LifeSci Venture Partners
Venture capitalNew York · Series A–Late Stage · 2 people tracked
Also known as LIFESCI VENTURE MANAGEMENT, LLC
Investment thesis
LifeSci Venture Partners focuses on the life sciences sector, backing biotech and pharmaceutical companies where its team brings clinical, scientific, and investment expertise. The firm emphasizes long-term conviction and hands-on partnership, playing an integral role in company formation and launch, guiding founders through investor storytelling, outreach, and closing strategies, and supporting portfolio companies over multiple ventures and across the investment lifecycle.
Source: firm website, verified Aug 25, 2026.
Team · 2 people
from the firm's website & public directories
What they invest in
from 8 of 9 portfolio companiesBiotech ×7Medical Devices ×4Digital Health ×3Healthtech ×3Deep Tech ×2Hardware ×1New Materials ×1
HQs:United States×7
Investments · 9 tracked
founders shown can be your intro pathBy year:2021 · 12020 · 12 dated
Erasca is a clinical-stage oncology company developing therapies targeting RAS- and MAPK pathway-driven cancers using a modality-agnostic approach including small molecules, large molecules, and protein degraders.
BiotechDeep TechDigital HealthMedical DevicesSan Diego, US
Jonathan E. Lim, M.D.(Chairman, CEO and Co-founder)Gary Yeung, CFA(Chief Business Officer)
BoardAlexander W. Casdin(Director)Pratik S. Multani, M.D.(Director)Valerie Harding-Start(Director)James A. Bristol, Ph.D.(Director)
Co-investorsAndreessen HorowitzARCH Venture PartnersEvolution VC PartnersFrazier Life SciencesCity Hill VenturesColt Ventures
BiotechTel Aviv
Shmuel Cabilly(Director)June Almenoff(Executive Officer)Ofer Tsimchi(Director)Rick D Scruggs(Executive Officer, Director)Nicolas Weinstein(Director)Alla Felder(Director)
PartnerPaul Yook· solo GP
Co-investorsHEALTHCARE ROYALTY PARTNERS
Orasis is a pharmaceutical company developing drugs for the eye, operating in the ophthalmology and eyecare space.
BiotechHealthtechMedical Devices
Co-investorsArboretum VenturesMaverick Ventures IsraelVisionary VenturesCatalio Capital ManagementJohnson & Johnson Innovation – JJDCSequoia Capital+1 more
Windsor, US
James P. Linton(Executive Officer, Director)Marc-Francois Pelletier(Executive Officer, Director)Paul Predki(Executive Officer, Director)Stephanie Ann George(Executive Officer)
BoardChris Camarsh(Director)
Board seatPaul Yook· per SEC Form D · $6M raise · filed Nov 2021
Co-investorsPrime Movers Lab
Biolinq develops the Shine sensor, a needle-free glucose monitor that measures glucose along with physical activity and sleep in a single wearable device.
Digital HealthHardwareMedical Devices
Jared Tangney(Founder)inRich Yangin
Co-investorsAble PartnersAlpha Wave GlobalAphelion CapitalAverin CapitalBOLD LongevityHikma Ventures+2 more
Biolinq develops a non-invasive glucose sensor that uses light to display glucose levels in real time, while also tracking activity and sleep to provide personalized health insights via a mobile app.
BiotechDigital HealthHealthtechMedical DevicesSan Diego, US
Jared Tangney(Executive Officer, Director, Promoter)inRichard Yang(Executive Officer, Director)Edward Kliphuis(Director)
BoardDaniel Bradbury(Director)inLana Ghanem(Director)
Co-investorsAlpha Wave GlobalBeyond CapitalBioBritJDRF T1D FundAphelion CapitalHikma Ventures+1 more
Company whose formation and launch the LifeSci team supported.
BiotechHealthtechSummit, US
Gregory Mayes(Executive Officer, Director, Promoter)Jouko Isojarvi(Executive Officer)Stephen D. Collins(Director)Warren Lammert(Director)Orrin Devinsky(Director)
BoardGerry Brunk(Director)in
PartnerPaul Yook· solo GP
Co-investorsLumira Ventures
Iridia develops Molecular Avatar Technology that embeds unalterable molecular identities and custom data (text, image, audio, or video) into physical products and materials such as paints, coatings, plastics, and liquids.
BiotechDeep TechNew Materials
PartnerPaul Yook· solo GP
Co-investorsConnecticut InnovationsDuke Capital PartnersLongley CapitalPrime Movers Lab
BiotechPittsburgh, US
Lalit Chordia(Director)Raymond K. Houck(President, Chief Executive Officer and Director of Issuer)Mazen Hanna(Chief Scientific Officer)Ira Kalfus(Chief Medical Officer of Issuer)Jason Bablak(Vice President, Regulatory Affairs)Brian Moyer(Vice President, Corporate Development & Finance)
PartnerPaul Yook· solo GP
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 2
IPOs and acquisitions across the tracked portfolioErascaNASDAQ: ERASRedHill Biopharma LtdNASDAQ: RDHL
Portfolio news
latest coverage across their companies
Biolinq · fiercebiotech.com · Sep 29, 2025
Biolinq · fiercebiotech.com · Sep 29, 2025
Frequently asked questions
- What stage does LifeSci Venture Partners invest at?
- LifeSci Venture Partners invests at the Series A, Series B, Series C, Late Stage stages.
- What sectors does LifeSci Venture Partners focus on?
- LifeSci Venture Partners focuses on Biotech, Healthtech, Medical Devices.
- Where is LifeSci Venture Partners located?
- LifeSci Venture Partners is headquartered in New York, US.
- Does LifeSci Venture Partners lead rounds?
- LifeSci Venture Partners typically participates in rounds rather than leading them.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.